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To elucidate biologic functions of hepatocyte growth
factor and the c-Met receptor in cutaneous wound heal-
ing, we analyzed expression and localization of hepato-
cyte growth factor and c-Met receptor and used a
strategy to neutralize endogenous hepatocyte growth
factor in a cutaneous wound healing model in mice.
Following excision of full-thickness skin on the dorsum
of mice, expression of both hepatocyte growth factor
and the c-Met receptor increased transiently in cuta-
neous tissues. Expressions of hepatocyte growth factor
increased as early as 2 d postwounding and reached a
peak on day 2, whereas the c-Met receptor expression
reached a peak 2^4 d postwounding. Immunolocaliza-
tion of the c-Met receptor indicated that c-Met receptor
expression was upregulated in keratinocytes, vascular
endothelial cells, and myo¢broblasts in granulation
tissue, hence these are potential target cells of hepato-
cyte growth factor.When normal rabbit IgG or neutra-
lizing anti-hepatocyte growth factor IgG was locally
and continuously delivered to subcutaneous lesions, the
number of capillary vessels decreased with the neutrali-
zation of hepatocyte growth factor and there was an as-
sociated decreased expansion of granulation tissue.
Likewise, retardation in re-epithelialization and the rate
of wound closure occurred with neutralization of endo-
genous hepatocyte growth factor on days 4 and 7 post-
wounding. Therefore, hepatocyte growth factor is
de¢nitely involved in enhancing cutaneous wound heal-
ing processes, including re-epithelialization, neovascu-
larization, and granulation tissue formation. Key words:
c-Met, growth factor, skin, re-epithelialization, myo¢broblasts.
J Invest Dermatol 120:335 ^343, 2003
C
utaneous wound healing proceeds in overlapping
phases of in£ammation, granulation tissue forma-
tion, angiogenesis, re-epithelialization, and remodel-
ing (Clark, 1996). These processes are regulated by
interactions between distinct cell types, including
keratinocytes, ¢broblasts, endothelial cells, and in£ammatory
cells that have migrated to the site of the wound. Past studies
indicated that these cellular interactions are mediated by cyto-
kines and growth factors secreted from these cells (Ferguson
and Leigh, 1998) and that they play a key part in orchestrating
integrated phases of the wound healing processes through
the regulation of cellular proliferation, di¡erentiation, and
apoptosis.
Hepatocyte growth factor (HGF), originally identi¢ed and
cloned as a mitogen for mature hepatocytes (Nakamura et al,
1984, 1989) exerts mitogenic, motogenic, morphogenic, and anti-
apoptotic activities for a wide variety of cells, through c-Met
receptor tyrosine kinase (Boros and Miller, 1995; Zarnegar and
Michalopoulos, 1995; Matsumoto and Nakamura, 1997). Particular
biologic and physiologic functions evoked by the association of
HGF and the c-Met receptor are morphogenesis and organization
of tissues during embryonic development and regeneration fol-
lowing tissue injury. In experimental models, a range of injuries
in organs such as the liver, kidney, and lung increases blood HGF
levels and tissue mRNA expression. Neutralization of HGF
following injury increased tissue damage and suppressed tissue
regeneration in cases of hepatic, renal, gastric, cardiac, and lung
injuries. Thus endogenous HGF plays a part in the regeneration
and protection of a variety of tissues (Matsumoto and Nakamura,
2001).
Potential involvement of HGF in cutaneous physiology and
wound healing was initially considered based on the ¢nding that
HGF stimulates keratinocyte migration and proliferation in vitro
(Matsumoto et al, 1991a; Sato et al, 1995). Other aspects implicating
the potential role of HGF in cutaneous physiology and wound
healing include its angiogenic action, and mitogenic and moto-
genic actions on melanocytes (Matsumoto et al, 1991b; Bussolino
et al, 1992). HGF locally delivered to avascular or lesions in a vas-
cular disease model induced neovascularization (Bussolino et al,
1992; Grant et al, 1993; Van Belle et al, 1998; Morishita et al, 1999).
Transgenic expression of HGF in an epidermis-speci¢c manner
a¡ects melanocyte development, leading to dermal melanocytosis
(Kunisada et al, 2000). Recent studies indicated that expression of
HGF and c-Met receptor increased in response to cutaneous
wounding (Cowin et al, 2001) and that transgenic overexpression
of HGF resulted in increased vascularization and granulation tis-
sue expansion (Toyoda et al, 2001).
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Despite previous studies implicating the potential involvement
of HGF in cutaneous wound healing, there has been no direct
evidence for the involvement of endogenous HGF in cutaneous
wound healing processes. One way to evaluate whether a growth
factor plays a part in the wound healing process is to eliminate
the growth factor from the wound environment. This could be
achieved by using a neutralizing antibody against the growth fac-
tors, such as transforming growth factor-b and vascular endothe-
lial growth factor (Shah et al, 1995; Howdieshell et al, 2001). In this
study, we investigated the function of HGF and the c-Met recep-
tor system, by blocking endogenous HGF with a neutralizing
antibody and use of a cutaneous wound healing mouse model.
Together with the locally upregulated expression of both HGF
and the c-Met receptor, we propose that endogenous HGF is in-
deed involved in cutaneous wound healing in that it a¡ects re-
epithelialization, angiogenesis, and granulation tissue formation.
MATERIALS AND METHODS
Animals and cutaneous wounding Eight week old female BALB/C
mice were used. Four full-thickness wounds (6 mm in diameter) were
made on the dorsum of each mouse using a punch biopsy instrument
(Maruho, Osaka, Japan). To observe the natural course of wound healing,
these mice were killed at indicated times and four skin samples from the
wounded sites were collected from each mouse. Two of them were used for
histologic analysis, and the other two for RNA and protein preparations. For
extraction of RNA and protein, skin samples, including the scab and the
complete epithelial margins were trimmed to 7^8 mm diameter, placed
immediately in liquid nitrogen, and stored at 801C until use.
To measure wound closure, long and short diameters of the wound were
measured using a dial caliper, and the wound area was determined using the
formula: wound area¼ (long diameter/2) (short diameter/2) 3.14. The
wound closure rate in percentage was calculated by the formula: wound
closure rate (%)¼ {(333.14^wound area)/333.14} 100. Zero
percent in wound closure rate is equivalent to no closure and 100% to
complete wound closure.
Reagents and materials An anti-HGF antibody was raised in rabbits by
immunizing with rat HGF (Ohmichi et al, 1998; Nakamura et al, 2000;
Sakamaki et al, 2002), and the IgG fraction was puri¢ed using protein A-
Sepharose (Pharmacia Biotech, Uppsala, Sweden). This anti-rat HGF
antibody cross-reacts with murine HGF, but not with human HGF. One
microgram of anti-rat HGF IgG neutralizes the biologic activity of at least
5 ng of murine HGF. This antibody was used for neutralization of HGF in
mice and for immunostaining.
Local administration of anti-HGF antibody or normal rabbit IgG
to mice Bioabsorbable hydrogel beads were used locally and
continuously to deliver IgG subcutaneously. Bioabsorbable hydrogel
forms a polyion complex with proteins, thus immobilizes them and
allows for continuous release of proteins through biodegradation of the
hydrogel (Tabata and Ikada, 1998, 1999; Tabata et al, 1999). In our
preliminary experiments, when injected subcutaneously, IgG molecules in
hydrogel beads were continuously released within 3 wk.
One day after wounding, phosphate-bu¡ered saline (PBS, 20 ml)
containing 400 mg anti-HGF antibody or normal rabbit IgG was added to
the freeze-dried gelatin hydrogel beads and the beads were left for 30 min
at room temperature. One hundred microliters saline was added, the
preparation well mixed, then subcutaneously injected under the wounded
site at a dose of 400 mg IgG per wound. Mice were killed on days 4, 7, and 14.
Measurement of HGF Tissues were homogenized in 10 volumes of
bu¡er composed of 20 mM Tris^HCl (pH 7.5), 2 M NaCl, 0.01% Tween
80, 1 mM phenylmethylsulfonyl £uoride, and 1 mM ethylenediamine
tetraacetic acid. The homogenate was centrifuged at 15,000 r.p.m.
(g=20,000) for 30 min and the resultant supernatant served as the tissue
extract. HGF in the tissue extract was measured using enzyme-linked
immunosorbent assay kits for rodent HGF (Institute of Immunology,
Tokyo, Japan).
Real-time quantitative reverse transcription^polymerase chain
reaction (reverse transcription^PCR) Total RNAwas prepared from
frozen skin samples, using ISOGEN (Nippon Gene, Tokyo, Japan). One
microgram of total RNA was reverse-transcribed into ¢rst strand cDNA
with a random hexaprimer using Superscript II reverse transcriptase (Life
Technologies Inc., Rockville, MD). Quantitative PCR was done as
described (Depre et al, 1998). Sequences for primers and TaqMan
£uorogenic probes (Perkin Elmer Biosystems, Foster City, CA) were as
follows: c-Met, forward primer, 50 -GTA CGG TGT CTC CAG CAT
TTT T-30, reverse primer, 50 -AGA GCA CCA CCT GCA TGA AG-30,
probe, 50(FAM)-ACC ACG AGC ACT GTT TCA ATA GGA CCC-
(TAMARA)30; HGF, forward primer, 50 -AAG AGT GGC ATC AAG
TGC CAG-30, reverse primer, 50 -CTG GAT TGC TTG TGA AAC ACC-
30, probe, 50(FAM)-TGA TCC CCC ATG AAC ACA GCT TTT TG-
(TAMARA)30 GAPDH, forward primer, 50 -CCA TCA CTG CCA CTC
AGA AGA C-30, reverse primer, 50 -TCA TAC TTG GCA GGT TTC
TCC A-30 probe, 50(FAM)-CGT GTT CCT ACC CCC AAT GTA TCC
GT(TAMARA)30. Experimental samples were matched to a standard
curve generated by amplifying serially diluted products, using the same
PCR protocol. To correct for any variability in RNA recovery and ensure
the e⁄ciency of reverse transcription, GAPDH cDNAwas ampli¢ed and
quantitated for each cDNA preparation.
Immunohistochemistry and histologic analysis To analyze
localization and expression of HGF and c-Met, skin samples were ¢xed in
70% ethanol, embedded in para⁄n, and sectioned. Tissue sections were
incubated with 10 mg per ml anti-rat HGF antibody (described above) or
anti-mouse c-Met rabbit polyclonal antibody (diluted 1 : 200, sp260; Santa
Cruz Biotechnology Inc., Santa Cruz, CA) for 2 h at room temperature.
After rinsing with PBS, the sections were incubated with Dako’s rabbit
Envision plus visualization system (DAKO, Glostrup, Denmark) for
30 min, followed by incubation with substrate solution containing
diaminobenzidine and hydrogen peroxide. The sections were counter-
stained with hematoxylin. To detect nonspeci¢c background staining, the
tissue sections were incubated with 10 mg per ml normal rabbit IgG or anti-
HGF and anti-c-Met antibodies, respectively, preabsorbed with an excess
amount of recombinant rat HGF and the antigenic synthetic peptide.
For blood vessel staining, 10% formalin-embedded tissue sections were
treated with 0.25% trypsin at room temperature for 30 min, washed in
PBS, and quenched with 3% hydrogen peroxide in PBS for 30 min. Then
sections were incubated with the anti-CD31/PECAM-1 antibodies (diluted
1 : 50, Pharmingen, San Diego, CA) for 2 h at room temperature, followed
by incubation with biotinylated horseradish peroxidase-conjugated rabbit
anti-rat IgG antibodies (diluted 1 : 200, DAKO) for 30 min. The reaction
was observed in substrate solution containing diaminobenzidine and
hydrogen peroxide. The sections were counterstained with hematoxylin.
The number of capillary lumens in the granulation tissue was counted in
the complete wound cross-sections immunostained for PECAM-1 at 100
magni¢cation.
To identify myo¢broblasts, 70% ethanol-¢xed tissue sections were
quenched with 3% hydrogen peroxide in PBS for 30 min, and then
incubated with anti-human a-smooth muscle actin (a-SMA) mouse
monoclonal IgG (EPOS System; DAKO) for 1 h. The reaction was
observed in substrate solution containing diaminobenzidine and hydrogen
peroxide. The sections were counterstained with hematoxylin. Images of
immunohistochemical staining of a-SMA were captured using a color
CCD camera and transferred to a computer. The staining intensity was
quanti¢ed using the NIH image program (version 1.62). In all cases, the
number of pixels for the positive staining within the granulation tissue
was divided by the total number of pixels for the granulation tissue. Thus
the expression of a-SMA was quantitatively presented as an arbitrary
unit.
Double staining of HGF/c-Met and PECAM-1, or HGF/c-Met and a-
SMA was done using the same ¢rst antibodies used for each staining as
described above. Tissue sections ¢xed in 70% ethanol were treated with
PBS containing 10% goat serum to block the nonspeci¢c binding of the
antibodies. After washing, sections were incubated with each set of ¢rst
antibodies at 41C overnight. The sections were then incubated for 30 min
with £uorescein isothiocyanate-conjugated anti-rabbit IgG (diluted 1 : 500;
Alexa Fluor 488; Molecular Probes, Inc., Eugene, OR) and rhodamine-
conjugated anti-rat IgG (diluted 1 : 500; Alexa Fluor 546; Molecular
Probes, Inc.), or with £uorescein isothiocyanate-conjugated anti-rabbit
IgG (diluted 1 : 500) and rhodamine-conjugated anti-mouse IgG (diluted
1 : 500, Alexa Fluor 546; Molecular Probes, Inc.), respectively. Sections
were observed using a £uorescence microscope.
To measure granulation tissue, tissue sections were stained with
hematoxylin and eosin. The area of granulation tissue was traced and
quanti¢ed in tissue sections perpendicular to the surface of the wound,
using a computerized morphometric analysis (NIH image, version 1.62).
For evaluation of re-epithelialization, the distance between the epithelial
tongues and the neoepidermal area at the center of wounded sites (3 mm
in width) were, respectively, measured in hematoxylin and eosin-stained
tissue sections perpendicular to the surface of the wound, using a
computerized morphometric analysis (NIH image, version 1.62).
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Measurement of DNA synthesis in epidermal keratinocytes DNA
synthesis of epidermal keratinocytes was measured by incorporation of
5-bromo-20 -deoxyuridine (BrdU) into nuclei and subsequent
immunohistochemical staining, using an anti-BrdU monoclonal antibody.
BrdU (Sigma, St Louis, MO) dissolved in saline was intraperitoneally
injected into mice at 100 mg per kg, 1 h prior to obtaining skin samples.
Immunohistochemical detection of BrdU-positive cells was done as
described elsewhere (Sakamaki et al, 2002). The BrdU-positive
keratinocytes within the neoepidermis were counted on days 4 and 7 at
100 magni¢cation under microscopy. In tissue sections for skin samples
with incomplete re-epithelialization, the numbers of BrdU-positive cells
were counted at both wound edges in a de¢ned area of 12 mm each. In
sections for skin samples with complete re-epithelialization, the central
area of the wounded site at 2 2 mm square was selected.
Statistical analysis For statistical analyses we used repeated measure
analysis of variance and subsequent Fisher’s protected least signi¢cant
di¡erence test. Di¡erences were considered to be signi¢cant at po0.05.
RESULTS
Change in c-Met receptor expression Following excision of
full-thickness skin (6 mm in diameter) o¡ the dorsum of mice,
the wounds were closed to approximately 50% of the original
wound area by day 4 postwounding and closure was completed
about 10 d after the wounding (Fig 1a). The histopathology on
day 2 represented the in£ammatory phase and the granulation
tissue formation progressed from days 4 to 7, with scar
resolution seen on day 14 postwounding (data not shown).
To determine the potential involvement of HGF in cutaneous
wound healing, we analyzed changes in c-Met mRNA levels in
the normal and wounded skin.We prepared total RNA from the
whole skin, including the wound, and changes in c-Met mRNA
expression were analyzed using real-time quantitative PCR (Fig
1b). c-Met mRNA levels in the whole skin were 2-fold higher
than that in normal skin 2 d after wounding, and a similar level
of increase in c-Met mRNA expression was seen on day 4. The
c-Met mRNA levels gradually decreased and reverted to normal
on day 14.
To determine the potential target cells of HGF during wound
healing, cutaneous tissues were immunohistochemically tested
for the c-Met receptor. In normal skin, the c-Met receptor was
positive in epidermis, hair follicles, arrector pili muscle, blood
vessels, and small populations of ¢broblast-like cells within the
dermis (Fig 2b).When the anti-c-Met antibody was preabsorbed
with antigenic peptide, speci¢c signals for c-Met were absent in
these cells (Fig 2a). c-Met protein expression was seen in
epidermal keratinocytes in the normal and wounded skin
throughout wound healing processes, but epidermal staining on
day 2 postwounding was more intense than in the normal skin
and in wounded skin at other stages of the healing (Fig 2c). On
day 4 postwounding, newly formed blood vessels in granulation
tissue were strongly c-Met-positive (Fig 2d). Although most of
the dermal ¢broblasts were c-Met negative in the normal skin, a
signi¢cant population of ¢broblastic cells gradually became c-
Met positive on day 4, especially at wound edges (Fig 2d). On
day 7, more than half of the dermal ¢broblastic cells
constituting the granulation tissue were positive for c-Met
immunostaining (Fig 2e,f). A large proportion of these c-Met-
positive ¢broblastic cells was a-SMA-positive myo¢broblasts
(see below). During resolution of the granulation tissue, the
number of c-Met-positive ¢broblastic cells in the granulation
tissue was reduced and only a few c-Met-positive ¢broblastic
cells were detectable on day 21 (Fig 2g).
To identify further the cells expressing c-Met receptor, tissue
sections on day 7 were subjected to double immuno-
histochemistry, using anti-c-Met antibody (Fig 3a,d) and an
antibody against PECAM-1 (Fig 3b) or a-SMA (Fig 3e).
Staining for PECAM-1 revealed microvascular endothelial
cells, whereas staining for a-SMA revealed myo¢broblasts in
granulation tissues. Merged images, c-Met/PECAM-1 (Fig 3c)
and c-Met/a-SMA (Fig 3f), respectively, showed that vas-
cular endothelial cells (arrowheads in Fig 3c indicate
the representatives) and myo¢broblasts were c-Met-positive,
suggesting that these cells were potential targets of HGF. In
addition, a comparison of a-SMA-staining and its merged
image with the c-Met receptor indicated that a signi¢cant
population of c-Met-positive ¢broblastic cells was negative for
a-SMA (Fig 3f).
Change in expression of HGF We next analyzed changes in
both HGF mRNA and protein levels in the whole skin of
normal and wounded lesions (Fig 4). On day 2 postwounding,
HGF mRNA levels increased 2-fold than that in the normal
skin. HGF mRNA levels reached a peak on day 4 and were 2.5
times higher than that in the normal skin. HGF mRNA levels
thereafter decreased and reached normal levels on day 14.
Similar to changes in HGF mRNA expression, protein levels of
HGF in skin tissue extracts increased following wounding. HGF
protein levels increased 3-fold over the normal level as early as 2
d after wounding, and it reached a peak on day 4. The HGF
protein levels reverted to normal on day 14.
To specify the localization of cells expressing HGF, tissue
sections obtained from normal and wounded skin were analyzed
immunohistochemically. In the normal skin, HGF expression was
localized in blood vessels, subcutaneous muscle, and some
keratinocytes in the epidermis and hair follicles (Fig 5b);
however, because staining in subcutaneous muscle and some
keratinocytes was also seen in control sections treated with
normal rabbit IgG (Fig 5a) or anti-HGF IgG preabsorbed with
recombinant rat HGF, staining in these cell types may be
nonspeci¢c. Nevertheless, as stronger staining was seen in
subcutaneous muscle cells with anti-HGF IgG than that
with normal IgG, these cells may possibly be the source of HGF.
On day 2, positive staining was detectable in the extracellular
matrix of the wounded area and some ¢broblasts at the wound
edge (Fig 5c). Because dermal ¢broblasts increased in the
wounded area on day 4, localization of HGF-positive cells
expanded and staining of these cells was more intense than
that seen on day 2 (Fig 5d^f). Thus, expression of HGF, as
detected immunohistochemically, seemed to correlate with
¢ndings obtained in a quantitative analysis of HGF using
enzyme-linked immunosorbent assay. In addition, it is
noteworthy that spindle-shaped cells just beneath the migrating
epithelium at the wound edge were strongly positive on
day 4 (Fig 5e). Expansion of granulation tissue was the highest
on day 7 (Fig 5g).Within the granulation tissue, capillary vessels
and the ¢broblastic cells surrounding the vessels were intensely
stained.
Figure1. Time course of wound closure (a) and regulation of c-Met
mRNA expression during cutaneous wound healing (b). (a) Follow-
ing full-thickness wounding (6 mm in diameter), wound areas were mea-
sured at indicated times during the healing process. Each value represents
the mean7SEM of values obtained from 28 wounds per each time point.
(b) c-Met mRNA was determined by real-time quantitative reverse tran-
scription^PCR. Each value represents the mean7SEM of values obtained
using seven wounds for each time point. nnnpo0.0001, nnpo0.001 vs day 0
(normal skin).
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To identify cellular sources of HGF in expanding granulation
tissue, tissue sections were double stained with anti-HGF
antibody (Fig 6a,d) and antibody against PECAM-1 (Fig 6b) or
a-SMA (Fig 6e). The merged image of HGF and PECAM-1
indicated that HGF was colocalized to PECAM-1-positive
vascular endothelial cells (Fig 6c, arrowheads indicate the
representatives). On the other hand, a-SMA-positive
myo¢broblasts were negative for HGF (Fig 6f). Instead, cells
positive for HGF were adjacent to the a-SMA-positive
myo¢broblast population. Perivascular smooth muscle cells
surrounding the endothelial cells were positive for HGF (Fig 6f,
arrowheads indicate the representatives). We also double stained
for HGF and Mac-1, a marker for macrophages, whereas
macrophages were negative for HGF (data not shown).
In the later stages of wound healing, HGF staining decreased,
and only the capillary vessels remained positive (Fig 5h).
Figure 2. Localization of the c-Met receptor in wounded mouse skin as detected immunohistochemically. c-Met immunolocalization is shown
in the normal intact skin (a,b) and wounded skin on days 2 (c), 4 (d), 7 (e,f), and 21 (g). To detect background staining, anti-c-Met antibody was preabsorbed
with antigenic synthetic peptide (a). Scale bars: (a^d,f) 50 mm; (e,g) 200 mm.
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Together with the upregulation of c-Met receptor expression,
these results suggest that HGF might play a part in cutaneous
wound healing following full-thickness skin excision.
Retarded wound healing by blockade of endogenous
HGF To de¢ne the involvement of HGF in cutaneous wound
healing, we blocked endogenous HGF using a neutralizing
antibody. For this purpose, a neutralizing antibody against HGF
Figure 3. Double staining of c-Met with PECAM-1 or a-SMA. Immunolocalization of c-Met (a,d), PECAM-1 (b), and a-SMA (e) were detected.
Merged images of c-Met (green) and PECAM-1 (red), and c-Met (green) and a-SMA (red) are shown in (c) and (f), respectively. Arrowheads in c indicate the
double-positive endothelial cells as representatives. Insets show magni¢ed views. Scale bars: in f refers to all sections and represents 100 mm, and in insets
represent 20 mm.
Figure 4. Changes in HGF mRNA and protein expression during
cutaneous wound healing. (a) Change in HGF mRNA expression.
HGF mRNA was determined using real-time quantitative reverse tran-
scription^PCR. Each value represents the mean7SEM of values obtained
from seven wounds for each time point. (b) Change in HGF protein level
as assessed by enzyme-linked immunosorbent assay. Each value represents
mean7SEM of values obtained using seven wounds (for days 0, 2, and 4)
or eight wounds (for days 7, 14, and 21). npo0.05, nnpo0.01, nnnpo0.0001
vs day 0 (normal skin).
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Figure 5. Localization of HGF in wounded mouse skin as detected
immunohistochemically. Immunolocalization of HGF is shown in the
normal intact skin (a,b) and wounded skin on days 2 (c), 4 (d^f), 7 (g), and
14 (h). Nonspeci¢c background staining was detected using normal rabbit
IgG (a). Scale bars: (a^c,e^h) 50 mm; (d) 200 mm.
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was locally and continuously delivered through bioabsorbable
gelatin hydrogel beads. Hydrogel beads containing normal
rabbit IgG and neutralizing anti-HGF IgG were, respectively,
injected subcutaneously at the wounded site on day 1
postwounding, a time when the wound was already dry and was
covered with a scab. Skin samples treated with hydrogel beads
were collected on days 4, 7, and 14 and examined histologically.
As in£ammation occurs in the early stage of wound healing,
we analyzed macrophage in¢ltration on days 4 and 7 by
immunohistochemistry with an anti-Mac-1 antibody. There was
no signi¢cant di¡erence in macrophage in¢ltration between
control and anti-HGF-treated mice (not shown), however,
indicating that endogenous HGF did not play a signi¢cant part
in macrophage in¢ltration.
Because angiogenesis plays a de¢nite role in cutaneous wound
healing and HGF is a potent angiogenic growth factor,
neovascularization was speci¢cally detected by immuno-
histochemical staining for PECAM-1. The capillary vessels
within the granulation tissue were counted (Fig 7). Compared
with wounded skin implanted with control normal IgG,
wounded skin treated with anti-HGF antibody had fewer
capillary vessels in the granulation tissue. The number of
capillary vessels in anti-HGF-treated skin decreased to 31% and
66%, respectively, of control skin on days 4 and 7 (Fig 7a).
Statistically signi¢cant di¡erences in the number of capillary
vessels between control and anti-HGF-treated skin samples were
observed both on days 4 (po0.01) and 7 (Fig 7b,c; po0.05).
When wound healing processes in control and anti-HGF-
treated skin samples were histopathologically examined in cross-
sections, retardation in granulation tissue expansion was observed
following blockade of endogenous HGF (Fig 8). The granulation
tissue of anti-HGF antibody-treated mice was very thin
compared with that of control mice on day 7 (Fig 8a,b).When
time-dependent change in expansion of granulation tissue was
analyzed, expansion of granulation tissue peaked on day 7 and
granulation tissue was on the way of resolution on day 14 in
control mice. In contrast, anti-HGF-treated skin samples showed
that expansion of granulation tissue was retarded and granulation
tissue was still gradually increasing until day 14 (Fig 8c). A
computer-aided image analyses of granulation tissues indicated
that the expansion of granulation tissues in control skin samples
reached 1.7170.13 mm2, but remained at 0.8370.12 mm2 in
anti-HGF-treated skin samples on day 7 (po0.001).
Following expansion of granulation tissue, remodeling of
granulation tissue occurs toward resolution, a process associated
with disappearance of a-SMA-positive myo¢broblasts. When
expression of a-SMA was evaluated by immunohistochemical
staining and its image analysis, a-SMA-positive myo¢broblasts,
which had accumulated in expanded granulation tissue on day 7,
were markedly decreased until day 14 in control mice (day 14;
0.1770.03, Fig 8d,e), indicating that the resolution progressed
during the observed period. In contrast, a-SMA-positive
myo¢broblasts increased during day 7 and day 14 in anti-HGF
antibody-treated mice (day 14; 0.4170.07, po0.01, Fig 8d,f),
suggesting retarded expansion and resolution of granulation
tissue.
In order to evaluate the e¡ect of anti-HGF-treatment on
re-epithelialization, we measured the distance between
the epithelial tongues and the neoepidermal area, using the
tissue sections of days 4 and 7, respectively (Fig 9a,b). In control
mice, the distance became as short as 3.0070.55 mm, whereas the
distance remained 4.6270.44 mm in anti-HGF antibody-treated
mice (po0.05). The area of the neoepidermis reached 0.4170.06
mm2 in control mice, whereas it remained 0.2570.03 mm2 in
anti-HGF antibody-treated mice (po0.05). These results
suggested that endogenous HGF stimulates re-epithelialization
during cutaneous wound healing. Because HGF has mitogenic
activity on epidermal keratinocytes, we also analyzed DNA
synthesis of epidermal cells by BrdU incorporation (Fig 9c).
BrdU-positive keratinocytes were counted within a de¢ned
neoepidermal area. In control mice, the numbers of BrdU-
positive keratinocytes were 121.5723.5 and 184.5725.2 on days 4
and 7, respectively. In anti-HGF-treated mice, the numbers were
125.578.8 and 89.7723.6, respectively. There was a statistically
signi¢cant di¡erence between control and anti-HGF-treated
mice on day 7 (po0.05, Fig 9c^e).
Figure 6. Double staining of HGF with PECAM-1 or a-SMA. Immunolocalization of HGF (a,d), PECAM-1 (b), and a-SMA (e) were detected.
Merged images of HGF (green) and PECAM-1 (red), and HGF (green) and a-SMA (red) are shown in (c) and (f), respectively. Arrowheads in c and f, respec-
tively, indicate the double-positive endothelial cells or perivascular smooth muscle cells as representatives. Insets show magni¢ed views. Scale bars: in f refers
to all sections and represent 100 mm, and in insets represent 20 mm.
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Finally, we measured wound closure in control and anti-HGF-
treated mice on days 4 and 7 postwounding (Fig 9f). In control
skin treated with normal IgG, wound closure reached 59.072.6%
and 91.572.5% on days 4 and 7, respectively. In contrast, in skin
treated with anti-HGF IgG, wound closure remained 43.373.2%
and 79.373.9%, respectively, on days 4 and 7. There were
statistically signi¢cant di¡erences in wound closure on both days
4 (po0.001) and 7 (po0.05); however, almost complete wound
closure was, respectively, seen by day 11 and day 12 in control
and anti-HGF-treated animals, and there were no statistically
signi¢cant di¡erences in wound closure between these mice
after day 8 postwounding. Thus, treatment with anti-HGF IgG
signi¢cantly retarded wound closure during earlier stages
following cutaneous wounding.
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Figure 7. Reduced neovascularization caused by neutralization of
endogenous HGF following cutaneous wounding. One day after
wounding, hydrogel beads containing normal rabbit IgG or anti-HGF
IgG were, respectively, injected subcutaneously under the wound site. (a)
Changes in the number of capillary vessels were detected immunohisto-
chemically using an anti-PECAM-1 antibody and capillary vessels within
the granulation tissue were counted on days 4 and 7. Each value represents
the mean7SEM of values obtained using six wounds per each group.
npo0.05, nnpo0.01, Control IgG vs anti-HGF antibody. (b,c) Distribution
of capillary vessels. Capillary vessels were stained using an anti-PECAM-1
antibody in wounded skin treated with normal rabbit IgG (b) and anti-
HGF antibody (c), respectively, on day 7. Scale bar: 100 mm.
Figure 8. Reduced granulation tissue expansion caused by neutrali-
zation of endogenous HGF following cutaneous wounding. One day
after wounding, hydrogel beads containing normal rabbit IgG or anti-HGF
IgG were, respectively, injected subcutaneously under the wound site. His-
tologic appearance of the wounded skin treated with normal rabbit IgG (a)
and anti-HGF antibody (b) on day 7. Scale bar: in b refers to both sections
and represent 500 mm. (c) Expansion of granulation tissue on days 4, 7, and
14. Each value represents the mean7SEM of values obtained using six
wounds per each group. NS, not signi¢cant, nnnpo0.001, Control IgG vs
anti-HGF antibody. (d) Expression of a-SMA in granulation tissue evalu-
ated by immunohistochemical staining and subsequent image analysis.
Each value represents the mean7SEM of values obtained using six
wounds per each group. NS, not signi¢cant, nnpo0.01, Control IgG vs
anti-HGF antibody. Immunolocalization of a-SMA-positive cells in the
wounded skin treated with normal rabbit IgG (e) and anti-HGF antibody
(f) on day 14. Scale bar: in f refers to both sections and represent 250 mm.
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DISCUSSION
Previous studies implicated the potential involvement of HGF
and the c-Met receptor in cutaneous wound healing. Earlier
in vitro approaches showed that HGF exerts mitogenic and moto-
genic responses in epidermal keratinocytes and melanocytes
(Matsumoto et al, 1991a, b; Sato et al, 1995). On the other hand, a
very recent study showed increases in expression of HGF and the
c-Met receptor in response to cutaneous wounding (Cowin et al,
2001), which were con¢rmed by this study. Another approach
utilizing transgenic mice showed increased granulation tissue
and vascularization due to transgenic overexpression of the HGF
gene (Toyoda et al, 2001); however, there has been no direct evi-
dence that endogenous HGF plays a part in cutaneous wound
healing. Together with rapid increases in expression of both
HGF and c-Met receptor genes and proteins, we have now
obtained direct evidence that endogenous HGF plays a de¢nite
part in cutaneous wound healing, determined using a strategy to
neutralize endogenous HGF.
Based on the potent stimulatory e¡ects of HGF on keratino-
cyte migration and proliferation (Matsumoto et al, 1991b), one an-
ticipated outcome as the result of blockade of HGF was
retardation in re-epithelialization and wound closure. Retarda-
tion in re-epithelialization and wound closure caused by neutra-
lization of HGF suggests that HGF is apparently involved in
epidermal wound healing, as well as in angiogenesis and granula-
tion tissue formation, during cutaneous full-thickness wound
healing. Supportive evidence that HGF is involved in epidermal
wound healing was noted in mice with a disrupted stat-3 gene in
a keratinocyte-speci¢c manner (Sano et al, 1999).With this muta-
tion in the stat-3 gene in mice, wound closure rate was remark-
ably retarded following cutaneous full-thickness wounding, and
this was associated with an impaired motogenic response in
epidermal keratinocytes induced by HGF, epidermal growth
factor, and transforming growth factor-a.
In addition to epidermal cell types, HGF targets vascular
endothelial cells and is a potent angiogenic factor (Bussolino
et al, 1992; Grant et al, 1993; Van Belle et al, 1998; Morishita et al,
1999). HGF induces autophosphorylation of the c-Met receptor
and HGF can induce proliferation and migration of endothelial
cells. Likewise, when HGF was applied to a model of hindlimb
ischemia, HGF induced new collateral blood vessels with a some-
what higher potency than that caused by vascular endothelial
growth factor and this potent angiogenic action of HGF was as-
sociated with enhanced vascular endothelial growth factor ex-
pression by HGF (Van Belle et al, 1998; Morishita et al, 1999).
Together with these previous reports indicating the potent angio-
genic action of HGF, the much less neovascularization caused by
neutralization of HGF indicates that HGF upregulated in cuta-
neous tissue physiologically supports angiogenic responses fol-
lowing cutaneous wounding. Because angiogenesis plays an
important part in tissue regeneration, including cutaneous wound
healing, HGF seems to participate in cutaneous wound healing,
targeting both epidermal and stromal endothelial cell types. Like-
wise, as angiogenesis is a de¢nite part of the granulation tissue
formation, suppression of granulation tissue expansion caused by
neutralization of HGF might be associated with reduced neovas-
cularization, at least in part. In this context, it is noteworthy that
transgenic overexpression of HGF in mice promoted neovascu-
larization and granulation tissue formation following cutaneous
wounding (Toyoda et al, 2001). Taken together with this trans-
genic approach (which is reciprocal to our approach to block en-
dogenous HGF), HGF participates in cutaneous wound healing,
by enhancing angiogenesis and granulation tissue formation, in
addition to epidermal wound healing.
Proliferation, phenotypic change, and apoptotic cell death of
dermal ¢broblasts are closely involved in granulation tissue for-
mation and the subsequent resolution (Tomasek et al, 2002). In
response to cutaneous injury, resident ¢broblasts in the surround-
ing tissue proliferate and a large population of the cells undergoes
phenotypic change to become a-SMA-positive myo¢broblasts.
This phenotypic change is associated with extracellular matrix
accumulation and subsequent wound contraction. Once these
processes have been accomplished, the breakdown of extracellular
matrix components and apoptotic cell death in myo¢broblasts
play a part in the resolution of granulation tissue (Darby et al,
1990; Desmouliere et al, 1995). Because c-Met receptor expression
have been noted predominantly but not exclusively in epithelial
and endothelial cells in various tissues (Boros and Miller, 1995;
Zarnegar and Michalopoulos, 1995; Matsumoto and Nakamura,
1997, 2001), an unexpected ¢nding in this study was the induction
of c-Met receptor expression in not all but a signi¢cant popula-
tion of myo¢broblasts in granulation tissue. Previous studies done
using other cell types indicated that HGF facilitates breakdown of
the extracellular matrix (Dunsmore et al, 1996; McCawley et al,
Figure 9. Retarded re-epithelialization and wound closure rate
caused by neutralization of endogenous HGF following cutaneous
wounding. One day after wounding, hydrogel beads containing normal
rabbit IgG or anti-HGF IgG were, respectively, injected subcutaneously un-
der the wound site. (a) Distance between the epithelial tongues on day 4.
Each value represents the mean7SEM of values obtained using six
wounds per each group. npo0.05, control IgG vs anti-HGF antibody. (b)
Area of neoepidermis on day 7. Each value represents the mean7SEM of
values obtained using six wounds per each group. npo0.05, control IgG vs
anti-HGF antibody. (c) DNA synthesis in neoepidermis as determined by
BrdU incorporation. BrdU-positive keratinocytes were counted in de¢ned
area (2 2 mm) on days 4 and 7. Each value represents the mean7SEM of
values obtained using six wounds per each group. NS, not signi¢cant,
npo0.05, control IgG vs anti-HGF antibody. Distribution of BrdU-positive
cells in the wounded skin treated with normal rabbit IgG (d) and anti-HGF
antibody (e) on day 7. Scale bar: in e refers to both sections and represent 50
mm. (f) Wound closure rate on days 4 and 7. Each value represents the
mean7SEM of values obtained using 36 wounds (for day 4) or 24 wounds
(for day 7) in each group. npo0.05, nnnpo0.001, control IgG vs anti-HGF
antibody.
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1998; Wang and Keiser, 2000). HGF regulates integrin-mediated
cellular adhesiveness to extracellular matrix proteins (Weimar et
al, 1997; Lai et al, 2000). Likewise, mitogenic actions of HGF are
cell type-dependent and HGF facilitate apoptosis in some cancer
cells (Conner et al, 1997; Arakaki et al, 1998; Matteucci et al, 2001).
Therefore, our data mean that HGF may possibly be involved in
regulating extracellular matrix remodeling and/or breakdown,
contractile function, and cell fate determination in myo¢bro-
blasts. Possible involvement of HGF in these processes remains
to be addressed in future studies.
In summary, our data show a de¢nite involvement of HGF in
cutaneous wound healing processes, including re-epithelializa-
tion, neovascularization, and granulation tissue formation. Based
on previous and present studies, therapeutic approaches for
the treatment of subjects with cutaneous injury and ulcer can be
considered.
This work was supported by Grants-in-Aid for Scienti¢c Research from the Ministry
of Education, Science,Technology, Sports, and Culture of Japan.We thank S. Mizu-
no, K. Bessho, and D. Tomioka for technical assistance with this research and M.
Ohara for language assistance.
REFERENCES
Arakaki N, Kazi JA, Kazihara T, Ohnishi T, DaikuharaY: Hepatocyte growth factor/
scatter factor activates the apoptosis signaling pathway by increasing caspase-3
activity in sarcoma 180 cells. Biochem Biophys Res Commun 245:211^215, 1998
Boros P, Miller CM: Hepatocyte growth factor: a multifunctional cytokine. Lancet
345:293^295, 1995
Bussolino F, Di Renzo MF, Ziche M, et al: Hepatocyte growth factor is a potent
angiogenic factor which stimulates endothelial cell motility and growth. J Cell
Biol 119:629^641, 1992
Clark RAF: Wound repair: overview and general considerations. In: Clark RAF
(ed.). The Molecular and Cellular Biology of Wound Repair. New York: Plenum
Press, 1996: pp 3^50
Conner EA,Wirth PJ, Kiss A, Santoni-Rugiu E,Thorgeirsson SS: Growth inhibition
and induction of apoptosis by HGF in transformed rat liver epithelial cells.
Biochem Biophys Res Commun 236:396^401, 1997
Cowin AJ, Kallincos N, Hatzirodos N, Robertson JG, Pickering KJ, Couper J, Bel-
ford DA: Hepatocyte growth factor and macrophage-stimulating protein are
upregulated during excisional wound repair in rats. Cell Tissue Res 306:
239^250, 2001
Darby I, Skalli O, Gabbiani G: Alpha-smooth muscle actin is transiently expressed
by myo¢broblasts during experimental wound healing. Lab Invest 63:21^29,
1990
Depre C, Shipley GL, Chen W, et al: Unloaded heart in vivo replicates fetal gene
expression of cardiac hypertrophy. Nat Med 4:1269^1275, 1998
Desmouliere A, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in
cellularity during the transition between granulation tissue and scar. Am J
Pathol 146:56^66, 1995
Dunsmore SE, Rubin JS, Kovacs SO, Chedid M, Parks WC,Welgus HG: Mechan-
isms of hepatocyte growth factor stimulation of keratinocyte metalloprotei-
nase production. J Biol Chem 271:24576^24582, 1996
Ferguson MWJ, Leigh IM: Wound healing. In: Champion RH, Burton JL, Burns
DA, Breathnach SM (eds).Textbook of Dermatology. Oxford: Blackwell Science
Ltd, 1998: pp 337^349
Grant DS, Kleinman HK, Goldberg ID, et al: Scatter factor induces blood vessel for-
mation in vivo. Proc Natl Acad Sci USA 90:1937^1941, 1993
Howdieshell TR, Callaway D,WebbWL, et al: Antibody neutralization of vascular
endothelial growth factor inhibits wound granulation tissue formation. J Surg
Res 96:173^182, 2001
KunisadaT,Yamazaki H, Hirobe T, et al: Keratinocyte expression of transgenic hepa-
tocyte growth factor a¡ects melanocyte development, leading to dermal mel-
anocytosis. Mech Dev 94:67^78, 2000
Lai JF, Kao SC, Jiang ST,Tang MJ, Chan PC, Chen HC: Involvement of focal adhe-
sion kinase in hepatocyte growth factor-induced scatter of Madin-Darby ca-
nine kidney cells. J Biol Chem 275:7474^7480, 2000
Matsumoto K, NakamuraT: Hepatocyte growth factor: renotropic role and potential
therapeutics for renal diseases. Kidney Int 59:2023^38, 2001
Matsumoto K, Nakamura T: Hepatocyte growth factor (HGF) as a tissue organizer
for organogenesis and regeneration. Biochem Biophys Res Commun 239:639^644,
1997
Matsumoto K, Hashimoto K, Yoshikawa K, Nakamura T: Marked stimulation of
growth and motility of human keratinocytes by hepatocyte growth factor.
Exp Cell Res 196:114^120, 1991a
Matsumoto K,Tajima H, Nakamura T: Hepatocyte growth factor is a potent stimu-
lator of human melanocyte DNA synthesis and growth. Biochem Biophys Res
Commun 176:45^51, 1991b
Matteucci E, Castoldi R, Desiderio MA: Hepatocyte growth factor induces
pro-apoptotic genes in HepG2 hepatoma but not in B16^F1 melanoma cells.
J Cell Physiol 186:387^396, 2001
McCawley LJ, O’Brien P, Hudson LG: Epidermal growth factor (EGF)- and scatter
factor/hepatocyte growth factor (SF/HGF)-mediated keratinocyte migration is
coincident with induction of matrix metalloproteinase (MMP)-9. J Cell Physiol
176:255^265, 1998
Morishita R, Nakamura S, Hayashi S, et al:Therapeutic angiogenesis induced by hu-
man recombinant hepatocyte growth factor in rabbit hind limb ischemia
model as cytokine supplement therapy. Hypertension 33:1379^1384, 1999
Nakamura T, Nawa K, Ichihara A: Partial puri¢cation and characterization of hepa-
tocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res
Commun 122:1450^1459, 1984
NakamuraT, NishizawaT, Hagiya M, et al:Molecular cloning and expression of hu-
man hepatocyte growth factor. Nature 342:440^443, 1989
Nakamura T, Mizuno S, Matsumoto K, SawaY, Matsuda H, Nakamura T: Myocar-
dial protection from ischemia/reperfusion injury by endogenous and exogen-
ous HGF. J Clin Invest 106:1511^1519, 2000
Ohmichi H, Koshimizu U, Matsumoto K, Nakamura T: Hepatocyte growth factor
(HGF) acts as a mesenchyme-derived morphogenic factor during fetal lung
development. Development 125:1315^1324, 1998
Sakamaki Y, Matsumoto K, Mizuno S, Miyoshi S, Matsuda H, Nakamura T: Hepa-
tocyte growth factor stimulates proliferation of respiratory epithelial cells dur-
ing postpneumonectomy compensatory lung growth in mice. AmJ Respir Cell
Mol Biol 26:525^533, 2002
Sano S, Itami S,Takeda K, et al: Keratinocyte-speci¢c ablation of Stat3 exhibits im-
paired skin remodeling, but does not a¡ect skin morphogenesis. EMBO J
18:4657^4668, 1999
Sato C, Tsuboi R, Shi CM, Rubin JS, Ogawa H: Comparative study of hepatocyte
growth factor/scatter factor and keratinocyte growth factor e¡ects on human
keratinocytes. J Invest Dermatol 104:958^963, 1995
Shah M, Foreman DM, Ferguson MW: Neutralisation of TGF-beta 1 and TGF-beta
2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scar-
ring. J Cell Sci 108(3):985^1002, 1995
TabataY, IkadaY: Protein release from gelatin matrices. Adv Drug Deliv Rev 31:287^
301, 1998
Tabata Y, Ikada Y: Vascularization e¡ect of basic ¢broblast growth factor released
from gelatin hydrogels with di¡erent biodegradabilities. Biomaterials 20:2169^
2175, 1999
TabataY, Nagano A, IkadaY: Biodegradation of hydrogel carrier incorporating ¢bro-
blast growth factor.Tissue Eng 5:127^138, 1999
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA: Myo¢broblasts and
mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol
3:349^363, 2002
Toyoda M, Takayama H, Horiguchi N, et al: Overexpression of hepatocyte growth
factor/scatter factor promotes vascularization and granulation tissue formation
in vivo. FEBS Lett 509:95^100, 2001
Van Belle E,Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, Isner JM:
Potentiated angiogenic e¡ect of scatter factor/hepatocyte growth factor via in-
duction of vascular endothelial growth factor: the case for paracrine ampli¢ca-
tion of angiogenesis. Circulation 97:381^390, 1998
Wang H, Keiser JA: Hepatocyte growth factor enhances MMP activity in human
endothelial cells. Biochem Biophys Res Commun 272:900^905, 2000
Weimar IS, de Jong D, Muller EJ, NakamuraT, van Gorp JM, de Gast GC, Gerritsen
WR: Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma
cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1
integrins. Blood 89:990^1000, 1997
Zarnegar R, Michalopoulos GK: The many faces of hepatocyte growth factor: from
hepatopoiesis to hematopoiesis. J Cell Biol 129:1177^1180, 1995
NEUTRALIZATION OF HGF 343VOL. 120, NO. 2 FEBRUARY 2003
